SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,152,000 | -10.8% | 36,821 | -28.0% | 0.08% | -12.2% |
| Q4 2016 | $1,291,000 | -2.4% | 51,136 | -4.4% | 0.09% | -7.2% |
| Q3 2016 | $1,323,000 | +29.2% | 53,487 | +6.4% | 0.10% | +26.0% |
| Q2 2016 | $1,024,000 | +30.8% | 50,260 | -2.2% | 0.08% | +40.0% |
| Q1 2016 | $783,000 | -3.1% | 51,365 | -14.6% | 0.06% | +1.9% |
| Q4 2015 | $808,000 | +16.9% | 60,145 | +22.2% | 0.05% | +12.5% |
| Q3 2015 | $691,000 | -48.5% | 49,228 | -55.7% | 0.05% | -41.5% |
| Q1 2015 | $1,342,000 | +47.0% | 111,020 | +0.9% | 0.08% | +54.7% |
| Q4 2014 | $913,000 | – | 109,990 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |